CSF-1R抑制剂ABSK021正式获CDE批准进入关键临床III期试验

array(1) { [449902]=> array(2) { [2]=> array(1) { [0]=> string(6) "中国" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }